BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 37985645)

  • 1. Cell replacement therapy with stem cells in multiple sclerosis, a systematic review.
    Christodoulou MV; Petkou E; Atzemoglou N; Gkorla E; Karamitrou A; Simos YV; Bellos S; Bekiari C; Kouklis P; Konitsiotis S; Vezyraki P; Peschos D; Tsamis KI
    Hum Cell; 2024 Jan; 37(1):9-53. PubMed ID: 37985645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell Therapy for Multiple Sclerosis.
    Genc B; Bozan HR; Genc S; Genc K
    Adv Exp Med Biol; 2019; 1084():145-174. PubMed ID: 30039439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remyelinating strategies: What can be learned from normal brain development.
    Shelestak J; Irfan M; DeSilva TM
    Curr Opin Pharmacol; 2022 Dec; 67():102290. PubMed ID: 36195009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
    Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
    Williams JL; Patel JR; Daniels BP; Klein RS
    J Exp Med; 2014 May; 211(5):791-9. PubMed ID: 24733828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis.
    Rodgers JM; Robinson AP; Miller SD
    Discov Med; 2013 Aug; 16(86):53-63. PubMed ID: 23911232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remyelination in multiple sclerosis.
    Lassmann H; Brück W; Lucchinetti C; Rodriguez M
    Mult Scler; 1997 Apr; 3(2):133-6. PubMed ID: 9291167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do central nervous system axons remyelinate?
    Nait-Oumesmar B; Lachapelle F; Decker L; Baron-Van Evercooren A
    Pathol Biol (Paris); 2000 Feb; 48(1):70-9. PubMed ID: 10729914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling mechanisms involved in the regulation of remyelination in multiple sclerosis: a mini review.
    Devanand M; V N S; Madhu K
    J Mol Med (Berl); 2023 Jun; 101(6):637-644. PubMed ID: 37084092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To what extent is oligodendrocyte progenitor migration a limiting factor in the remyelination of multiple sclerosis lesions?
    Franklin RJ; Blakemore WF
    Mult Scler; 1997 Apr; 3(2):84-7. PubMed ID: 9291159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
    J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials.
    Sutiwisesak R; Burns TC; Rodriguez M; Warrington AE
    Expert Opin Investig Drugs; 2021 Aug; 30(8):857-876. PubMed ID: 34126015
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular approaches for stimulating CNS remyelination.
    Miller RH; Bai L
    Regen Med; 2007 Sep; 2(5):817-29. PubMed ID: 17907933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.
    Xiao J; Yang R; Biswas S; Zhu Y; Qin X; Zhang M; Zhai L; Luo Y; He X; Mao C; Deng W
    Mol Neurobiol; 2018 Apr; 55(4):3152-3171. PubMed ID: 28466274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.